Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Theorem Appoints Biopharma Development EVP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Theorem Appoints Biopharma Development EVP

Industry veteran Treiber to lead clinical development across a wide range of therapeutic areas

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Scott P. Treiber, Ph.D., has been appointed executive vice president and general manager at Theorem Clinical Research. Dr. Treiber will oversee all aspects of Theorem’s biopharmaceutical development, including early phase first-in-human and proof-of-concept studies and Phase II-IV studies across a wide range of therapeutic areas.
 
Previously, Dr. Treiber held executive positions within the CRO and pharma industries. Dr. Treiber is a founding member of the Clinical Research Exchange and is active in the Chicagoland Chapter of the Association of Clinical Research Professionals.
 
“Scott is an extraordinary individual with valuable experience in clinical development, medical affairs, data management and other areas of biopharmaceutical development,” said John Potthoff, Theorem president and chief executive officer. “He brings expertise in central nervous system, oncology, cardiology, infectious diseases, respiratory and other prime therapeutic areas. We couldn’t have asked for a more perfect fit.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics